+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Knee Replacement Market Report and Forecast 2023-2031

  • PDF Icon


  • 147 Pages
  • April 2023
  • Region: Global
  • Expert Market Research
  • ID: 5786902
Global Knee Replacement Market Outlook
The value of the global knee replacement market was USD 9.62 billion in 2022, driven by the increasing demand of minimally invasive knee replacement surgeries across the globe. The market is expected to grow at a CAGR of 4.89% during the forecast period of 2023-2031 to reach a value of USD 14.78 billion by 2031.

Knee Replacement Market: Introduction

Knee replacement, also known as knee arthroplasty, is a surgical procedure in which a damaged or diseased knee joint is replaced with an artificial joint, called a prosthesis. The prosthesis is designed to mimic the shape and function of a natural knee joint, allowing patients to regain mobility and alleviate pain caused by conditions such as osteoarthritis, rheumatoid arthritis, and post-traumatic arthritis.

Knee replacement surgery can be performed as a partial knee replacement, where only the damaged part of the knee joint is replaced, or as a total knee replacement, where the entire knee joint is replaced. The surgery typically involves a hospital stay of a few days and a recovery period of several weeks, during which patients work with physical therapists to regain strength and mobility.

The global knee replacement market is growing rapidly, driven by the increasing prevalence of knee disorders and the growing demand for minimally invasive surgical techniques. Key players in the knee replacement market include Zimmer Biomet, Stryker Corporation, Smith & Nephew, and DePuy Synthes. These companies are investing in research and development to improve the design and performance of knee prostheses and to develop new techniques for knee replacement surgery.

Despite its benefits, knee replacement surgery also carries some risks, such as infection, blood clots, and nerve damage. Patients should discuss the potential risks and benefits of knee replacement surgery with their healthcare provider to determine if it is the right choice for their individual needs.

Knee Replacement Epidemiology

The epidemiology of knee replacement surgery varies by region and demographic factors such as age, gender, and underlying medical conditions. In general, knee replacement is more common in older adults, with the highest prevalence in those aged 65 and older.

In the United States, approximately 1 million knee replacement surgeries are performed each year, according to the American Academy of Orthopaedic Surgeons. The prevalence of knee replacement surgery is also increasing in other regions, including Europe, Asia-Pacific, and Latin America.

Osteoarthritis is the most common reason for knee replacement surgery, accounting for approximately 80% of cases. Other indications for knee replacement surgery include rheumatoid arthritis, post-traumatic arthritis, and avascular necrosis.

Overall, knee replacement surgery is a common and effective treatment option for individuals with severe knee pain and limited mobility due to knee joint damage or disease. With advancements in surgical techniques and prosthetic design, knee replacement surgery continues to be an important area of research and innovation in the healthcare industry.

Global Knee Replacement Market Segmentations

Market Breakup by Procedure

  • Total Knee Arthroplasty
  • Partial Knee Arthroplasty
  • Revision Knee Arthroplasty

Market Breakup by Implant Type

  • Fixed Bearing
  • Mobile Bearing
  • Others

Market Breakup by Material

  • Metal on Plastic
  • Ceramic on Plastic
  • Ceramic on Ceramic
  • Metal on Metal

Market Breakup by End User

  • Hospitals
  • Orthopaedic Centres
  • Ambulatory Surgical Centres
  • Others

Market Breakup by Region

North America

  • United States of America
  • Canada


  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Global Knee Replacement Market Scenario

The global knee replacement market is expected to grow significantly in the coming years, driven by factors such as an increasing prevalence of knee disorders, a growing elderly population, and advances in surgical techniques and prosthetic design.

North America dominated the global knee replacement market in 2020, accounting for the largest revenue share. This can be attributed to a high prevalence of knee disorders in the region, coupled with a well-established healthcare infrastructure and higher healthcare spending. However, the Asia-Pacific region is expected to witness the fastest growth over the forecast period due to the increasing adoption of knee replacement surgery in emerging economies such as China and India.

However, the knee replacement market also faces challenges such as high costs associated with surgery, the risk of complications such as infection, and the need for post-operative rehabilitation.

Additionally, the COVID-19 pandemic has had a significant impact on the knee replacement market, as elective surgeries have been postponed or cancelled in many regions, leading to a temporary decline in demand. Nevertheless, the knee replacement market is expected to recover and continue to grow in the long term as the global population ages and the demand for joint replacement surgery increases.

Key Players in the Global Knee Replacement market

The report gives an in-depth analysis of the key players involved in the global knee replacement market. The companies included in the market are as follows:
  • Zimmer Biomet
  • Stryker Corporation
  • Smith and Nephew Plc
  • B.Braun Melsungen AG
  • Johnson & Johnson Services Inc
  • MicroPort Scientific Corporation
  • ConforMIS, Inc
  • Corin Group
  • Exatech, Inc
  • DJO Global Inc
  • Baumer Holdings
  • SurgTech Inc
  • Wright Medical Group N.V
  • NOV
  • Medacta International

This product will be delivered within 5-7 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Knee Replacement Overview
3.1 Guidelines and Stages
3.2 Pathophysiology
3.3 Screening and Diagnosis
3.4 Treatment Pathway
4 Patient Profile
4.1 Patient Profile Overview
4.2 Patient Psychology and Emotional Impact Factors
4.3 Risk Assessment and Treatment Success Rate
5 Knee Arthritis Epidemiology Analysis
5.1 Epidemiology Overview (2016-2031)
5.2 North America Knee Arthritis Epidemiology (2016-2031)
5.3 Europe Knee Arthritis Epidemiology (2016-2031)
5.4 Asia-Pacific Knee Arthritis Epidemiology (2016-2031)
5.5 Latin America Knee Arthritis Epidemiology (2016-2031)
5.6 Middle East & Africa Knee Arthritis Epidemiology (2016-2031)
6 Global Knee Replacement Market Overview
6.1 Global Knee Replacement Market Historical Value (2016-2022)
6.2 Global Knee Replacement Market Forecast Value (2023-2031)
7 Global Knee Replacement Market Landscape
7.1 Knee Replacement: Developers Landscape
7.1.1 Analysis by Year of Establishment
7.1.2 Analysis by Company Size
7.1.3 Analysis by Region
7.2 Knee Replacement: Product Landscape
7.2.1 Analysis by Procedure
7.2.2 Analysis by End Implant type
7.2.3 Analysis by Material
7.2.4 Analysis by End User
8 Knee Replacement Challenges and Unmet Needs
8.1 Treatment Pathway Challenges
8.2 Compliance and Drop-Out Analysis
8.3 Awareness and Prevention Gaps
9 Cost of Treatment
10 Global Knee Replacement Market Dynamics
10.1 Market Drivers and Constraints
10.2 SWOT Analysis
10.3 Porter’s Five Forces Model
10.4 Key Demand Indicators
10.5 Key Price Indicators
10.6 Industry Events, Initiatives, and Trends
10.7 Value Chain Analysis
11 Global Knee Replacement Market Segmentation
11.1 Global Knee Replacement Market by Procedure
11.1.1 Market Overview
11.1.2 Total Knee Arthroplasty
11.1.3 Partial Knee Arthroplasty
11.1.4 Revision Knee Arthroplasty
11.2 Global Knee Replacement Market by Implant Type
11.2.1 Market Overview
11.2.2 Fixed Bearing
11.2.3 Mobile Bearing
11.2.4 Others
11.3 Global Knee Replacement Market by Material
11.3.1 Market Overview
11.3.2 Metal on Plastic
11.3.3 Ceramic on Plastic
11.3.4 Ceramic on Ceramic
11.3.5 Metal on Metal
11.4 Global Knee Replacement Market by End User
11.4.1 Market Overview
11.4.2 Hospitals
11.4.3 Orthopedic Clinics
11.4.4 Ambulatory Surgery Centres
11.4.5 Others
11.5 Global Knee Replacement Market by Region
11.5.1 Market Overview
11.5.2 North America
11.5.3 Europe
11.5.4 Asia Pacific
11.5.5 Latin America
11.5.6 Middle East and Africa
12 North America Knee Replacement Market
12.1 Market Share by Country
12.2 United States of America
12.3 Canada
13 Europe Knee Replacement Market
13.1 Market Share by Country
13.2 United Kingdom
13.3 Germany
13.4 France
13.5 Italy
13.6 Others
14 Asia Pacific Knee Replacement Market
14.1 Market Share by Country
14.2 China
14.3 Japan
14.4 India
14.5 ASEAN
14.6 Australia
14.7 Others
15 Latin America Knee Replacement Market
15.1 Market Share by Country
15.2 Brazil
15.3 Argentina
15.4 Mexico
15.5 Others
16 Middle East and Africa Knee Replacement Market
16.1 Market Share by Country
16.2 Saudi Arabia
16.3 United Arab Emirates
16.4 Nigeria
16.5 South Africa
16.6 Others
17 Regulatory Framework
17.1 Regulatory Overview
17.1.1 US FDA
17.1.2 EU EMA
17.1.5 Others
18 Patent Analysis
18.1 Analysis by Type of Patent
18.2 Analysis by Publication year
18.3 Analysis by Issuing Authority
18.4 Analysis by Patent Age
18.5 Analysis by CPC Analysis
18.6 Analysis by Patent Valuation
18.7 Analysis by Key Players
19 Grants Analysis
19.1 Analysis by year
19.2 Analysis by Amount Awarded
19.3 Analysis by Issuing Authority
19.4 Analysis by Grant Application
19.5 Analysis by Funding Institute
19.6 Analysis by NIH Departments
19.7 Analysis by Recipient Organization
20 Clinical Trials Analysis
20.1 Analysis by Trial Registration Year
20.2 Analysis by Trial Status
20.3 Analysis by Trial Phase
20.4 Analysis by Therapeutic Area
20.5 Analysis by Geography
21 Funding and Investment Analysis
21.1 Analysis by Funding Instances
21.2 Analysis by Type of Funding
21.3 Analysis by Funding Amount
21.4 Analysis by Leading Players
21.5 Analysis by Leading Investors
21.6 Analysis by Geography
22 Partnership and Collaborations Analysis
22.1 Analysis by Partnership Instances
22.2 Analysis by Type of Partnership
22.3 Analysis by Leading Players
22.4 Analysis by Geography
23 Supplier Landscape
23.1 Zimmer Biomet
23.1.1 Financial Analysis
23.1.2 Product Portfolio
23.1.3 Demographic Reach and Achievements
23.1.4 Mergers and Acquisitions
23.1.5 Certifications
23.2 Stryker Corporation
23.2.1 Financial Analysis
23.2.2 Product Portfolio
23.2.3 Demographic Reach and Achievements
23.2.4 Mergers and Acquisitions
23.2.5 Certifications
23.3 Smith and Nephew Plc
23.3.1 Financial Analysis
23.3.2 Product Portfolio
23.3.3 Demographic Reach and Achievements
23.3.4 Mergers and Acquisitions
23.3.5 Certifications
23.4 B.Braun Melsungen AG
23.4.1 Financial Analysis
23.4.2 Product Portfolio
23.4.3 Demographic Reach and Achievements
23.4.4 Mergers and Acquisitions
23.4.5 Certifications
23.5 Johnson & Johnson Services Inc.
23.5.1 Financial Analysis
23.5.2 Product Portfolio
23.5.3 Demographic Reach and Achievements
23.5.4 Mergers and Acquisitions
23.5.5 Certifications
23.6 MicroPort Scientific Corporation
23.6.1 Financial Analysis
23.6.2 Product Portfolio
23.6.3 Demographic Reach and Achievements
23.6.4 Mergers and Acquisitions
23.6.5 Certifications
23.7 ConforMIS, Inc.
23.7.1 Financial Analysis
23.7.2 Product Portfolio
23.7.3 Demographic Reach and Achievements
23.7.4 Mergers and Acquisitions
23.7.5 Certifications
23.8 Corin Group
23.8.1 Financial Analysis
23.8.2 Product Portfolio
23.8.3 Demographic Reach and Achievements
23.8.4 Mergers and Acquisitions
23.8.5 Certifications
23.9 Exatech, Inc.
23.9.1 Financial Analysis
23.9.2 Product Portfolio
23.9.3 Demographic Reach and Achievements
23.9.4 Mergers and Acquisitions
23.9.5 Certifications
23.10 DJO Global Inc.
23.10.1 Financial Analysis
23.10.2 Product Portfolio
23.10.3 Demographic Reach and Achievements
23.10.4 Mergers and Acquisitions
23.10.5 Certifications
23.11 Baumer Holdings
23.11.1 Financial Analysis
23.11.2 Product Portfolio
23.11.3 Demographic Reach and Achievements
23.11.4 Mergers and Acquisitions
23.11.5 Certifications
23.12 SurgTech Inc.
23.12.1 Financial Analysis
23.12.2 Product Portfolio
23.12.3 Demographic Reach and Achievements
23.12.4 Mergers and Acquisitions
23.12.5 Certifications
23.13 Wright Medical Group N.V.
23.13.1 Financial Analysis
23.13.2 Product Portfolio
23.13.3 Demographic Reach and Achievements
23.13.4 Mergers and Acquisitions
23.13.5 Certifications
23.14 NOV
23.14.1 Financial Analysis
23.14.2 Product Portfolio
23.14.3 Demographic Reach and Achievements
23.14.4 Mergers and Acquisitions
23.14.5 Certifications
23.15 Medacta International
23.15.1 Financial Analysis
23.15.2 Product Portfolio
23.15.3 Demographic Reach and Achievements
23.15.4 Mergers and Acquisitions
23.15.5 Certifications
24 Knee Replacement - Distribution Model (Additional Insight)
24.1 Overview
24.2 Potential Distributors
24.3 Key Parameters for Distribution Partner Assessment
25 Key Opinion Leaders (KOL) Insights (Additional Insight)
26 Company Competitiveness Analysis (Additional Insight)
26.1 Very Small Companies
26.2 Small Companies
26.3 Mid-Sized Companies
26.4 Large Companies
26.5 Very Large Companies
27 Payment Methods (Additional Insight)
27.1 Government Funded
27.2 Private Insurance
27.3 Out-of-Pocket

Companies Mentioned

  • Zimmer Biomet
  • Stryker Corporation
  • Smith and Nephew plc
  • B.Braun Melsungen AG
  • Johnson & Johnson Services Inc.
  • Microport Scientific Corporation
  • Conformis, Inc.
  • Corin Group
  • Exatech, Inc.
  • Djo Global Inc.
  • Baumer Holdings
  • Surgtech Inc.
  • Wright Medical Group N.V.
  • Nov
  • Medacta International



Table Information